Loading clinical trials...
Loading clinical trials...
Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lung...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Merck Sharp & Dohme LLC
NCT07120789 · Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT04778046 · Interstitial Lung Disease, COPD, and more
NCT06481852 · Pulmonary Arterial Hypertension
NCT06477640 · Pulmonary Arterial Hypertension PAH
Pulmonary Associates, PA ( Site 1008)
Phoenix, Arizona
University of California San Diego Health ( Site 1002)
La Jolla, California
UCSF Helen Diller Medical Center at Parnassus Heights ( Site 1019)
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions